What are the chances your Friday FDA approval theory applies to vitiligo? The evidence below looks pretty compelling to me:
JC said around June 17th in the investor briefing.
The soft tissue FDA submission was announced in Australia was on 12 December 2022 and FDA approval was on 8 June 2023 so JC delivered on his guidance, and the FDA delivered on their goal to take action on an application under breakthrough device designation within 6 months:
The FDA submission for Vitiligo was announced in Australia on 19 December 2022 so if the FDA can deliver on their goal again, we could get the news tomorrow = Friday:
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.045(2.68%) |
Mkt cap ! $122.9M | |||
| Open | High | Low | Value | Volume |
| $1.71 | $1.74 | $1.70 | $650.7K | 379.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 1506 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| AVH (ASX) Chart |